AV
Atlas Venture Fund XI, L.P.
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Atlas Venture Fund XI, L.P.. Insider active across 2 companies, notably Korro Bio, Inc.. Cumulatively, 19 disclosures have been recorded. History available since 22 June 2026. The latest transaction was filed on 14 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Atlas Venture Fund XI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
31,888 股@ US$13.81Common StockSEC144:0001628280-26-061898
8,450 股@ US$13.060.058% mcap2.8% 占其流量Common StockSEC144:0001628280-26-061593
249 股@ US$13.730.0018% mcap0.1% 占其流量Common StockSEC144:0001628280-26-059122
23,584 股@ US$13.220.15% mcap8.1% 占其流量Common StockSEC144:0001628280-26-058030
1,359,674 股@ US$25.960.74% mcap58.5% 占其流量CommonSEC144:0001628280-26-057190
268,354 股@ US$26.170.14% mcap28.1% 占其流量CommonSEC144:0001628280-26-056843
1,775 股@ US$13.490.012% mcap0.7% 占其流量Common StockSEC144:0001628280-26-055858
153,966 股@ US$22.840.089% mcap37.6% 占其流量CommonSEC144:0001628280-26-047533
817 股@ US$14.000.0056% mcap1.0% 占其流量Common StockSEC144:0001628280-26-047352
253,039 股@ US$23.070.15% mcap62.4% 占其流量CommonSEC144:0001628280-26-047357
85,955 股@ US$13.650.55% mcap100.0% 占其流量Common StockSEC144:0001628280-26-046978
102,969 股@ US$20.940.044% mcap14.5% 占其流量CommonSEC144:0001628280-26-046094
162,954 股@ US$20.610.069% mcap22.7% 占其流量CommonSEC144:0001628280-26-045819
12,699 股@ US$20.330.0053% mcap1.5% 占其流量CommonSEC144:0001628280-26-045611
41,345 股@ US$13.710.28% mcap16.5% 占其流量Common StockSEC144:0001628280-26-045302
50,530 股@ US$20.260.021% mcap5.8% 占其流量CommonSEC144:0001628280-26-045293
101,579 股@ US$13.900.69% mcap41.1% 占其流量Common StockSEC144:0001628280-26-044982
77,855 股@ US$20.870.033% mcap9.1% 占其流量CommonSEC144:0001628280-26-044986
21,339 股@ US$12.990.14% mcap8.0% 占其流量Common StockSEC144:0001628280-26-044738
About Atlas Venture Fund XI, L.P.
Atlas Venture Fund XI, L.P. is a shareholder of Dyne Therapeutics, Inc. and Korro Bio, Inc. The declarant has 12 filings in total, and across the 12 recent filings available between 2026-06-22 and 2026-07-07, they show only sales for EUR 18590470, with the stated transaction nature being a notice of proposed sale (Form 144).